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1. Indroduction 
Osteoporosis is a disease in which the density and quality of bone are reduced, leading to 
weakness of the skeleton and increased risk of fracture. Osteoporosis literally means 
"porous bone". When a bone has become osteoporotic or osteopenic (low bone mass), the 
risk of a fracture increases. The forearm, spine and hip are the most common fracture sites, 
accounting for more than 80 percent of all fractures. Osteoporosis and associated fractures 
are an important cause of mortality and morbidity. 20 percent of hip fractures lead to death 
within a year. Osteoporosis is a widespread public health problem. The costs to national 
healthcare systems from osteoporosis-related hospitalization are staggering. In the US, the 
cost to the health care system associated with osteoporotic fractures is approximately $17 
billion annually. This converts to more than $45 million a day! Each hip fracture represents 
an estimated $40,000 in total medical costs. 
Human skeleton makes up a load-bearing structure for motor organs and it constitutes a 
location for attachment of tendons and ligaments. Mature bone has a lamellar structure with 
layers and comprises compact (cortical) bone and trabecular (spongy) bone. Cortical layer 
consists of cylindrically arranged lamellae, while spongy bone is composed of 
threedimensional, irregular trabeculae in the form of a network. Space between trabeculae is 
filled with hematopoietic system cells and adipose tissue (Fig. 1). Matrix of the bone consists 
of organic compounds called osseine, which is responsible for bone elasticity as well as of 
mineral compounds: magnesium phosphate, calcium carbonate and calcium 
hydroxyapatite, which provide bones a particular hardness. Deviation from proper level of 
minerals in relation to organic compounds might cause lack of bone elasticity, thus its 
brittleness. Main mineral compound of bones is calcium hydroxyapatite with crystal size that 
ranges from 4-50 nm. Hydroxyapatite is a ‘warehouse’ for the most of calcium (99%) and 
phosphorus (85%) contained within the body. Hydroxyapatite crystals account to as much 
as 77% of organic stroma the bones are composed of (Fig. 1). 
Moreover, hydroxyapatite is the main mineral component of dentine (Fig. 2). Dentine 
comprises essential part of the mass of hard tissues, which human teeth are made of. In the 
area of the crown, the dentine is covered with enamel, while in the area of the root – with 
cementum. Teeth (singular: tooth) are dense structures found in the jaws of many 
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vertebrates. They have various structures to allow them to fulfill their different purposes. 
The primary function of teeth is to tear, smell and chew food, while for carnivores it is also a 
weapon. Therefore, teeth have to withstand a range of physical and chemical processes, 
including compressive forces (up to ~ 700 N), abrasion and chemical attack due to acidic 
foods or products of bacterial metabolism. 
 
Fig. 1. Section of a bone 
Nowadays dentists, in their practice, often encounter problems of bone defects which occur 
as a result of removal of bone cyst or through alveolar process artophy. Bone graft is a 
standard procedure during treatment of such defects. The locations from which transplants 
are taken include: mentum (area next to canines), cranial vault and iliac ala. This 
methodology has some advantages, e.g. no graft rejection reaction, however, its 
fundamental drawback is the fact that this requires additional surgical intervention, which 
might lead to some disorders in the location the grafts are taken from.  
Due to the abovementioned facts, a great emphasis is on searching for bone-replacing 
materials which would allow for filling of bone defects resulting from a variety of reasons. 
Such materials would eliminate many complications which occur during use of materials of 
autogenic 1, allogenic2 or xenogenic 3 origins.  
Development of materials for medicine applications was first recorded in 1860, when doctor 
J. Lister developed aseptic techniques used in surgery. Previous attempts with use of 
biomaterials frequently ended up with infections spreading throughout the patients’ bodies, 
thus causing demise. Since then, further developments started to spread rapidly. Some 
discoveries were made almost ‘by the way’, e.g. during the Second World War lack of 
                                                 
1Graft from the same body 
2Material for the graft taken from a specimen of the same species, genetically different than recipient 
3Graft taken from a specimen of different species 
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chronic adverse reactions was observed in wounded pilots as some parts of aircraft 
canopies, made of polymethyl methacrylate, were left lodged in their bodies for a longer 
time. Nowadays, this material is widely used, e.g. it replaces parts of skull bones.  
 
Fig. 2. Section of a tooth 
2. Material for Implants – Biomaterials 
According to the definition adopted by the European Society for Biomaterials, biomaterials 
include the compounds which are not medicines or combination of natural and synthetic 
substances, and, which might replace a part or the whole tissue or organ.  
Materials that implants are made of 4 must not be hazardous for human body, i.e. 
carcinogenic, toxic or radioactive, they have to be resistant to corrosion (depending on the 
environment they work within), biocompatible (the materials which show tissue 
compatibility and do not trigger allergic reactions), well tolerated by living tissues. Implant 
acquire their fundamental properties and biocompatibility through specific chemical 
constitution of a material it is made of. It is characterized by biotolerance, .i.e. biological 
compatibility and harmony of interaction with living matter. Biotolerance causes that an 
implant, having been implemented into the body, does not trigger acute or chronic reactions 
or inflammatory condition in adjacent tissues. The biggest importance for implant 
acceptance by a tissue and for the process of osseointegration is the composition of its 
surface layer. Another important issue is osteointegration5, i.e. ingrowth of bone tissue into 
the implant surface, and, in consequence, integration of the graft with the bone.  
                                                 
4Medical devices made of one or more biomaterials which might be located in the body, partly or 
entirely under the skin 
5Osteointegration - ingrowth of living bone tissue into the titanium implant surface 
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Biomaterials are used, among other things, in orthopaedics, cardiology, nanosurgery and 
dentistry (Fig. 3).  
There are several groups of materials which have been used and which replace steels and 
temporarily damaged or ill organs or their parts (Fig. 4).  
Analysis of clinical experience in terms of human body reactions to metallic implants allows 
to emphasise the following complications: 
 immunological oversensitivity, which contributes to bone necrosis or soft tissue 
necrosis,  
 thrombuses,  
 risk of immediate and subsequent infections,  
 reduction in cells’ resistance to bacteria, resulting from reduction of pH factor near the 
graft,  
 weakening of neutrophiles and macrophages that facilitate development of bacterial 
flora, caused by electrical potential gradient at the interface of metal – body fluid. 
Lack of metallic biomaterial which are entirely neutral to human body causes that research 
works toward searching, improvement and modification of such materials are a necessity.  
One of the suggestions for improvement of biotolerance in applied metallic materials is the 
use of ceramic coatings. 
 
Fig. 3. Areas of application for biomaterials 
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Fig. 4. Comparison of biomaterials and areas of their application  
Bioceramics, despite their high hardness and, in consequence, higher brittleness, have an 
essential advantage i.e. their porosity, which ensures integration of vascularised soft tissue, 
which, in effect, becomes a permanent connection. Good adhesion of the material grafted 
into the bone is a very important problem of implantology. There have been attempts to 
solve this problem through application of bioactive ceramics which ‘spontaneously’ 
connects with the bone.  
Ensuring effective biological connection of ceramics (composite) with the bone depends on 
pores size and their spatial distribution, i.e.:  
 pores over 5m – no tissue ingrowing occurs, 
 over 25m – ingrowing of fibrous tissue and vessels,  
 over 50m – mineralization of ingrown pores,  
 over 75m – mineralization occurs at the depth of 500m, 
 większe od 100m – mineralization occurs even at the depth of over 1000m, ensuring 
proper bone formation. 
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According to many authors, the most optimal pore size maintains at the level of 100-500m. 
Phase and chemical composition of bioactive materials is selected so as to ensure that 
implant surface adjacent to tissue or body fluids constitutes an intermediate layer which 
connects an implant with bone tissue. A variety of materials which fulfil such criteria have 
been developed in recent years. The most frequently used bioceramics, due to their high 
mechanical, corrosion and wear resistance as well as their non-toxicity and biocompatibility, 
include oxides: Al2O3 (whose use for medicine is dated back to the thirties of the past 
century), ZrO2 and calcium phosphates (Tab. 1, 2).  
 
Table 1. Comparison of calcium phosphates existing at the temperature of 250C  
 
Table 2. Properties of human bone and comparison with selected materials  
Calcium orthophosphates are chemical compounds of special interest in many 
interdisciplinary fields of science, including geology, chemistry, biology and medicine.  The 
main driving force behind the use of calcium orthophosphates as bone substitute materials 
is their chemical similarity to the mineral component of mammalian bones and teeth 
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calcium orthophosphates are also known to be osteoconductive (able to provide a scaffold 
or template for new bone formation).the major limitations to use calcium orthophosphates 
as load-bearing bioceramics are their mechanical properties; namely, they are brittle with a 
poor fatigue resistance. In general, calcium orthophosphate bioceramics should be 
characterized from many viewpoints such as the chemical composition (stoichiometry and 
purity), homogeneity, phase distribution, morphology, grain sizes and shape, grain 
boundaries, crystallite size, crystallinity, pores, cracks, surface, etc. From the chemical point 
of view, the vast majority of calcium orthophosphate bioceramics is based on HA, ǃ-TCP,  
ǂ-TCP.  
A sintering procedure appears to be of a great importance to manufacture bulk bioceramics 
with the required properties. Usually, this stage is carried out according to controlled 
temperature programs of electric furnaces in adjusted ambience of air with necessary 
additional gasses; however, always at temperatures below the melting points of the 
materials. The heating rate, sintering temperature and holding time depend on the starting 
materials. For example, in the case of HA, these values are in the ranges of 0.5–3 °C/min, 
1000–1250 °C and 2–5 h, respectively. In the majority cases, sintering allows a structure to 
retain its shape. However, this process might be accompanied by a considerable degree of 
shrinkage, which must be accommodated in the fabrication process. 
Hydroxyapatite  (HA, HAp), with formula of Ca10(PO4)6(OH)2, is a compound which is 
chemically and mineralogically similar to inorganic substances from which human bone 
tissue, including teeth, is made of. Hydroxyapatite crystallizes stechiometrically in 
monoclinic system, while synthetic, mineralogical and biological one shows hexagonal 
structure (Fig. 5). In its chemical constitution, HA contains 1.8% of H2O. While heated, HA is 
stabile until 1703K, then it irreversibly looses hydroxyl groups, gradually changing into 
oxyapatite Ca10(PO4)6O. At 1503K it might lose as much as 75% of water, maintaining its 
apatite structure. 
 
Fig. 5. Crystallographic structure of hydroxyapatite 
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Hydroxyapatite material is osteoconductive6 and, on smaller scale, osteoinductive, thus 
implants made of this material can be directly integrated with the bone. After implantation 
of the material, osteogenesis7 occurs and the layer which connects the surface of the 
hydroxyapatite graft with bone tissue appears. HA is a material which is characterized with 
small biodegradation rate – resorption in the body amounts to from 5 to 15% yearly. The 
process of connection of implant with the bone takes ca. a year.  
Application of phosphate-calcium ceramics for implantology depend mainly, in terms of 
their bioactivity, on their: 
1. porosity, 
2. chemical and phase composition, 
3. crystallinity degree.  
Hydroxyapatite ceramics have been successfully used in dentistry, facial surgery, 
orthopaedics and otolaryngology in the form of shaped pieces and porous granules for 
replenishment of bone defects in the locations which do not bear mechanical load (e.g. 
malleus). Wider use of this ceramics, despite their best bioactivity and biocompatibility, is 
limited due to their poor mechanical properties. 
The researchers have frequently attempted to improve mechanical strength and resistance to 
cracking through introduction of ZrO2, Y2O3 and CaO oxides into HA. Zirconium oxide, 
commonly used for production of femoral joint prostheses, while its impact on composite 
reinforcement is determined, among other things, by stress distribution in material during 
polymorphous tm (tetragonal to monoclinic) transition of ZrO2 during martensite 
transition.  
Thus it seems to be necessary to strive for development of a composite with HAp matrix, while 
reinforcing phase should consist of other materials well-tolerated by living tissues. 
3. HA+ZrO2 ceramic composites 
From the standpoint of common use of hydroxyapatite and HAp-based composites (with 
addition of ZrO2 phase) for medicine, it is very important to determine such percentage 
content of ZrO2 phase addition in the mixture that invariable or predictable dimensions of 
an implant or coating are maintained after the process of sintering.  
The goal of the investigations: The investigations aimed to determine thermal stability in 
hydroxyapatite and HAp + ZrO2 composites and the impact of 8%wt. and 20%wt. Y2O3 
additions of ZrO2 on phase composition in the composites obtained after the process of 
sintering.  
Thesis: Increase in the amount of addition of ZrO2 zirconium phase, modified with 8% wt. 
and 20% wt. Y2O3, to hydroxyapatite bioceramics leads to reduction of shrinkage triggered 
by sintering of the mixture prepared from both powders. Zirconium phase in HA + ZrO2 
mixture stabilizes the dimensions of final, sintered composite.  
                                                 
6 Being a source of substances that induct bone genesis in the tissues surrounding the bone defect 
7 The process of bone creation on connective-tissue or cartilaginous base 
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In order to prepare sinters based on HAp, powder metallurgy method was employed in this 
study, which allowed to obtain porous materials with beneficial biofunctional properties. 
The obtained materials, as a group of biomaterials which are widely used in bone surgeries, 
were then subjected to structural and phase tests. The mathematical description that allows for 
assessment of volume shrinkage in HAp + ZrO2 sinters was developed after the process of 
sintering, which is a significant result of this work.  
3.1 Procedure for the experiment 
During the investigations the following powders were used: 
 HAp (Ca10(PO4)6(OH)2) with average particle size of 50 micrometers, characterized  
by high purity level (over 99%wt.): Pb = 0.8ppm, As1.0 ppm, Cd, Hg0.1 ppm;  
Ca/P = 1.67, 
 ZrO2 oxide with addition of 8% (wt.) Y2O3  (YSZ – Yttria Stabilized Zirconia) (Fig. 6), 
 ZrO2 oxide with addition of 20% wt. Y2O3.   
Both zirconium oxide powders were 100%crystalline, while their grains were of regular, 
spherical shape of grains.  
 
Fig. 6. Types of zirconium ceramics depending on the content of Y2O3 modifying phase 
The composites based on hydroxyapatite with addition of different content of the both 
zirconium ceramic powders modified with ytrrium oxide were prepared: 
 100% HAp,  
 (90%÷30%) HAp + (10%÷70%) YSZ; where: (YSZ-Ytrria Stabilized Zirconium, means 
ZrO2+8%wt.Y2O3) 
 (80%÷30%) HAp + (20%÷70%) ZrO2 + 20%wt. Y2O3  
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3.2 Stereological tests of the used powders 
Histograms of distribution of stereological parameters in the investigated powders, whose 
morphology is shown in Fig. 7, are presented in Fig. 10-12 (for hydroxyapatite) and in Fig. 8, 
13-15 (for zirconium ceramics with addition of 8%wt. Y2O3) and Fig. 9, 16-18 (for zirconium 
ceramics with addition of 20%wt. Y2O3). 
Shape factor R was calculated using the following formula:  
 R=L2/(4A) (1) 
where: L-particle circumference, A-particle surface area. 
 
   
Fig. 7. Microphotograph of the powder: HAp 
 
 
Fig. 8. Microphotograph of the powder: YSZ 
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Fig. 9. Microphotograph of the powder: ZrO2+20%Y2O3 
 
Fig. 10. Surface area histogram 
in particle of HAp powder 
Fig. 11. Chord histogram in 
particles of HAp powder 
Fig. 12. Shape factor histogram 
in particles of HAp powder 
 
Fig. 13. Surface area histogram 
in particle of ZrO2 + 8wt.% 
Y2O3 powder 
Fig. 14. Chord histogram in 
particles of ZrO2 + 8wt.% 
Y2O3 powder 
Fig. 15. Shape factor histogram 
in particles of ZrO2 + 8wt.% 
Y2O3 powder 
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Fig. 16. Surface area histogram 
in particle of ZrO2 + 20wt.% 
Y2O3 powder 
Fig. 17. Chord histogram in 
particles of  
ZrO2 + 20wt.% Y2O3 powder 
Fig. 18. Shape factor histogram 
in particles of ZrO2 + 20wt.% 
Y2O3 powder 
After homogenization of the mixtures of selected particular compositions, powders were 
then axially compressed with the load of 110 MPa (Fig. 19) and dried in laboratory dryer. As 
a result of the procedure the moulded pieces were obtained with nominal dimensions of: 
=30mm, h=5mm. 
 
Fig. 19. Diagram of the mould used for powder compaction 
Compaction of the powders was carried out in the following stages: 
- movement of particles in relation to each other, 
- elastic deformations in particles, 
- crushing of particles.  
The obtained moulded pieces where then subjected to the process of sintering at the 
temperature of 1100-13000C for two hours. 
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As a result of physical and chemical processes that accompany the process of sintering, a 
change in properties and dimensions of the moulded pieces occurred. 
3.3 Microstructure tests 
Macroscopic changes in the product during sintering are a result of numerous physical and 
chemical processes that occur in the material. The moulded pieces were subjected to 
microstructure tests using JEOL JSM 5400 scanning microscope.  
Analysis of one-phase system (100 % HA) (Fig.20) and sinters of HA+ZrO2 before and after 
sintering (1100-1300oC) (Fig.21) reveals that grains after the process of sintering were 
partially crushed and they were adjacent to each other. After the process of sintering a 
reduction in porosity (i.e. in number and size of pores) occurred. 
 
Fig. 20. 100% HAp powder after sintering 
 
Fig. 21. Powder of: 50%HA + 50% ZrO2 (8%wt.Y2O3) after sintering 
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Analysis of Hap+ZrO2 sinters reveals that decreases largeness of grain and increase 
largeness of pore. 
In the case of calcium orthophosphates, several specific processes occur during sintering. 
Firstly, moisture, carbonates and all other volatile chemicals remaining from the synthesis 
stage, such as ammonia, nitrates and any organic compounds, are removed as gaseous 
products. Secondly, unless powders are sintered, the removal of these gases facilitates 
production of denser ceramics with subsequent shrinkage of the samples. Thirdly, all 
chemical changes are accompanied by a concurrent increase in crystal size and a decrease in 
the specific surface area. Fourthly, a chemical decomposition of all acidic orthophosphates 
and their transformation into other phosphates takes place. 
3.4 X-Ray structural analysis 
It seems to be necessary, from the standpoint of wider use of composite materials, to 
determine phase stability in the obtained composites. After the sintering process, phase 
analysis was carried out using Seifert 3003 T-T X-ray diffractometer with radiation of 
wavelength of KCo=0,17902 nm. 
First stage encompassed phase analysis of the powders. X-ray quality analysis of 
hydroxyapatite powder revealed its 100% crystallinity and presence of hexagonal phase of 
HA with the following parameters of the cell: a = b = 9,418 nm, c= 6,884 nm, space group 
P63/m. 
As results from the analysis of the obtained diffractogram, ZrO2 modified with 8% wt. of 
Y2O contains two polymorphous modifications of zirconium dioxide: tetragonal phase and 
small amount of monoclinic phase.  
ZrO2 powder with addition of 20% wt. of Y2O3 mainly consisted of monoclinic and small 
amount of regular phase. Lack of tetragonal phase, which indicates stabilization of 
zirconium phase proves undoubtedly that the powder is only a mixture of the two oxides 
rather than their solution.  
Analysis of phase composition for sintered samples of 100% HA revealed that they are 
composed of hexagonal phase – HAp and TCP, CaO phases. 
Diffractogram of sinters with analysed percentage contents of both powders are presented 
in: Fig. 22 for HA+ ZrO2 (modified with 8wt.% Y2O3) and Fig. 23 for HA + ZrO2 sinters ( 
with addition of 20wt.% Y2O3). 
Analysis of diffractograms of sinters that contain from 20-60% of YSZ phase revealed 
presence of HA phase, ZrO2 with tetragonal modification, insignificant amount of TCP and 
CaO phase. The amount of TCP and CaO decreases as zirconium phase addition rises for all 
sintering temperatures. 
The results of analysis of sinter diffractograms with addition of ZrO2+20%Y2O3 phase were 
comparable – as HA, TCP and insignificant amount of CaO phase (that gradually 
disappears as zirconium phase addition rises) occur in it. The peaks from tetragonal ZrO2 
phase were also observed; its presence seems to be of much interest since monoclinic phase 
predominated in initial powder. 
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Fig. 22. Collective diffractogram for sinters of HA+ZrO2 modified with 8% wt. Y2O3 
 
Fig. 23. Collective diffractogram for sinters of HA + ZrO2 with addition of 20% wt. Y2O3 
The process of sintering of HA + ZrO2 (+20%Y2O3) mixtures caused, according to the 
investigations, decline in monoclinic modification and its transition into tetragonal 
modification. Thus, the applied treatment resulted in mt transition, i.e. transformation of 
monoclinic form into tetragonal one took place. This fact can be explained by impact of CaO 
phase that appeared during hydroxyapatite decomposition on stability of tetragonal phase. 
Moreover, presence of monoclinic modification of ZrO2 in ZrO2+20%wt.Y2O3 powder 
proves undoubtedly the absence, in the case of the analysed composition, of solid solution of 
Y+3 ions in crystallographic network of zirconium oxide. The process of sintering could have 
led to appearance of such solutions and also to stabilization of tetragonal phase.  
The conducted analysis allows to observe that addition of zirconium phase impacts on rise 
in temperature of hydroxyapatite decomposition, which manifests in decline in CaO and 
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TCP phase and rising addition of ZrO2+8wt.%Y2O3 and ZrO2+20%wt.Y2O3 phases in 
powder mixtures. 
3.5 Apparent density of moulded pieces and sinters 
During development of materials for implants one must consider proper density of 
HA+ZrO2 composites. Proper level of density must ensure that specific strength properties 
are obtained as well as necessary open porosity that allows for ingrowing of the implant. In 
order to achieve this, apparent density measurements in the obtained moulded pieces and 
sinters were carried out. The results are presented in Fig. 24 and 25. 
 
Fig. 24. Change in sample density depending on percentage content of ZrO2 + 8 % wt. Y2O3 
before and after sintering 
 
Fig. 25. Change in sample density depending on percentage content of ZrO2 + 20% wt. Y2O3 
before and after sintering 
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Densities of moulded pieces and sinters assessed in the case of addition of the same amounts 
of ZrO2 modified with 8% wt. as well as 20% wt.Y2O3 to HA were comparable. Density of 
moulded pieces (HA+ ZrO2) increases with addition of zirconium oxide, which is connected 
with difference in the value of density in both powders ( HA=3gcm-3,  ZrO2=6gcm-3). In 
consideration of the density in each sample before and after sintering, it is remarkable that the 
difference between density of a moulded piece and the sinter decreases with addition of 
zirconium phase. A density of sintered pieces increases with sintering temperatures. 
This fact proves that addition of zirconium ceramics (regardless of ittria content used as modifier) 
stabilizes dimensions of the sintered composite based on HA. 
Analysis of test results reveals that, in the case of composite samples with addition of ZrO2 
modified with both 8% wt. and 20% wt.Y2O3, density of the moulded piece equals density of 
the sinter at the content of ca. 70% of zirconium phase. This means that the obtained sinter is 
characterized by zero shrinkage after the treatment.  
3.6 Mathematical description of the shrinkage in HA+ZrO2 composites 
An essential issue is to determine exact percentage content of addition of ZrO2 phase to the 
mixture in terms of their impact on dimensional stability.  
In order to formulate generalized dependencies in the obtained sinters, the analysis of 
dependencies between content of zirconium phase and the shrinkage was carried out using 
correlation and regression of two variables.  
For the obtained experimental points linear regression equations were matched by means of 
least squares method, correlation coefficient was calculated and the tests were made with 
the significance level of =0.05 using the following dependencies:  
 significance test for correlation coefficient 
 
2
2
1
r
t n
r
 

 (2) 
where: n – number of degrees of freedom, r – correlation coefficient 
 significance test for coefficients of regression equation  
  20
1
n
i
r i
A A
t x x
S 
  ;  2
1
1
ˆ
2
n
r i
i
S y y
n 
   ;
 2
0 1
2
1
n
i
i
n
r
i
i
n x x
B B
t
S
x





 (3) 
where: Sr – remaining deviation, A, A0 – values of direction component, B, B0 – absolute term. 
 confidence interval for direction component of simple regression 
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where:  value of T-Student statistics for n-2 degrees of freedom and the accepted confidence 
level 1-. 
 asymptotes equation for confidence corridor 
 1 1 1 2 2 2ˆ ˆy B A y B A x     (5) 
 confidence corridor for simple regression 
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The results of the performed calculations are presented in Fig. 26-27. These calculations 
show strong dependence between the contents of zirconium phase and sample shrinkage 
after sintering process. It was also proved by high values of correlation coefficient r2>0.98. 
On the basis of regression curves one can determine the content of zirconium phase at which 
sinters based on hydroxyapatite show zero shrinkage. In the case of HAp + ZrO2 (8%wt. 
Y2O3) ceramics, a simple extrapolation method enabled determination of ZrO2+8%wt. Y2O3 
powder content which ensured zero shrinkage at the level of 70.6% wt. Content interval 
determined from confidence corridor amounts to from 65% to 76% wt. 
Similar considerations were made for HAp + ZrO2 (20 %wt. Y2O3) ceramics and they 
enabled determination of the amount of addition ZrO2+20 %wt. Y2O3 powder that 
corresponded with zero shrinkage in sinter at the level of 76% wt.. Confidence corridor 
range for these samples ranged from 70% to 82% wt. 
 
 
Fig. 26. Correlation chart with confidence corridor for HAp + ZrO2 (8 %wt. Y2O3) sinters in 
1100-1300oC 
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Fig. 27. Correlation chart with confidence corridor for HAp + ZrO2 (20 %wt. Y2O3) sinters 
4. Summary and conclusions 
 A sintering procedure appears to be of a great importance to manufacture bulk 
bioceramics with the required mechanical properties. 
 Hydroxyapatite ceramics have been found to be one of the best implantation materials 
successfully used in bone surgeries and dentistry. This ceramics allows for their easy 
connection with other types of materials, which creates opportunity for development of 
composites for medical applications. 
 For the purposes of this work and creation of ceramic composites (HA+ZrO2), powder 
metallurgy method was employed, which allowed to receive porous materials based on 
hydroxyapatite.  
 Phase analysis of the sinters obtained from mixtures of powders (based on 
hydroxyapatite with addition of zirconium oxide modified with 8% wt. Y2O3 and 20% 
wt. Y2O3 revealed presence of HA phase as well as TCP and CaO phases that prove 
decomposition of hydroxyapatite. The investigations also revealed that addition of 
zirconium phase impacts on rise in temperature of hydroxyapatite decomposition, 
which manifests in decline of CaO and TCP phases with addition of ZrO2+8wt.%Y2O3 
ZrO2+20%wt.Y2O3 phases in powder mixtures. 
 In consideration of the density in each sample before and after sintering, it is 
remarkable that the difference between density of a moulded piece and the sinter 
decreases with addition of zirconium phase. This fact proves that addition of zirconium 
ceramics (regardless of ittria content used as modifier) stabilizes dimensions of the 
sintered composite based on HA. 
 From the standpoint of common use of hydroxyapatite and HAp-based composites 
(with addition of ZrO2 phase) for medicine, it is of key importance to determine such 
percentage content of ZrO2 phase addition in the mixture that invariable or predictable 
dimensions of the implant or coating are maintained after the process of sintering. The 
presented mathematical description enables assessment of the amount of zirconium 
oxide (with different addition of stabilizing Y2O3 phase) in the mixture of powders that 
ensures zero shrinkage in sinters.  
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